Kenvue Inc. (NYSE:KVUE), the maker of Tylenol, has reportedly defended itself against a lawsuit in which consumers claimed being misled into overpaying for “Rapid Release” gelcaps, arguing that these gelcaps did not relieve pain any faster than less expensive Tylenol tablets.
The drug is used to treat mild to moderate pain and to reduce fever.
The lawsuit hinged on a 2018 study indicating that the gelcaps took slightly longer to dissolve—3.94 minutes compared to 3.56 minutes for regular tablets.
Also Read: Listerine-Maker Kenvue’s Stock Soars On Strong Q2 Sales From Its Essential Health Unit, Reaffirms ...
